for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

Cardiac resynchronization therapy (CRT) was proposed in the 1990s as a new therapy for
patients with heart failure and wide QRS with depressed left ventricular ejection fraction …

Background Increasing evidence supports a link between myocardial fibrosis (MF) and
ventricular arrhythmias. Objectives The purpose of this study was to determine whether …

Aims This study aimed to investigate the impact of cardiac resynchronization therapy with a
defibrillator (CRT-D) on mortality, comparing it with CRT with a pacemaker (CRT-P) …

Aims Randomized controlled trials have shown that cardiac resynchronization therapy
(CRT) prolongs survival in patients with heart failure. No studies have explored survival after …

Background Current guidelines recommend considering multiple factors while deciding
between cardiac resynchronization therapy with a defibrillator (CRT-D) or a pacemaker …

Aims The very long-term outcome of patients who survive the first few years after receiving
cardiac resynchronization therapy (CRT) has not been well described thus far. We aimed to …

Aims Cardiac resynchronization therapy with (CRTD) or without (CRTP) defibrillator is
recommended in selected patient with systolic chronic heart failure and wide QRS. There is …

Background: Cardiac resynchronization therapy (CRT) represents a major medical advance
in patients with heart failure with electrical dyssynchrony to improve symptoms, reduce …

The use of cardiac implantable electronic devices in the management of patients with heart
rhythm conditions is well established. As the population ages, the use of cardiac implantable …